Bendeka® Bendamustine HCl 25 mg/mL Injection - Teva Pharmaceuticals
USAMP#96162303SKU: 63459034804Bendeka®
License Required
Product Spotlight
- High-purity Bendeka® Bendamustine HCl 25 mg/mL Injection designed for precise dosing in cancer treatment.
- Manufactured by Teva, ensuring top-quality and reliability for chemotherapy protocols.
- Comes in a convenient 4 mL multiple-dose vial, facilitating ease of use for healthcare professionals.
- Approved antineoplastic agent for the treatment of certain types of cancer, including lymphoma.
- Formulated without latex, catering to patients with latex allergies.
- Essential for pharmacy inventory catering to oncology departments.
